Taiwan Medical Imaging

Kaohsiung, Taiwan (Taiwan AI Labs has an office in Kaohsiung and collaborates with local medical centers there). All Taiwan companies → — Founded 2019

Imaging AI Specialist

Neurology Oncology Radiology

Oncology AI

Unfunded

Claim this company

Products

TAIMedImg DeepMets

Taiwan Medical Imaging Co.

Oncology AI

TAIMedImg DeepMets is an AI-powered software for automated brain metastasis contouring on MRI, accelerating radiation therapy planning and enhancing diagnostic accuracy and workflow efficiency.

Contact for pricing.

See all 1 product →

About Taiwan Medical Imaging

Taiwan Medical Imaging Co., Ltd., operating under the brand TAIMedimg, is a healthcare AI company dedicated to advancing medical imaging and patient care through trustworthy artificial intelligence. The company delivers validated AI medical imaging models to clinics and hospitals, aiming to enhance disease detection, prognosis, tracking, and the generation of medical reports. Their solutions are designed to serve as smart assistants for preventive healthcare, clinical diagnosis, and treatment, offering real-time interpretation of imaging and data, facilitating timely diagnoses and treatment plans for physicians.

TAIMedimg is a subsidiary of Taiwan AI Labs and is at the forefront of developing AI-powered diagnostic tools. A notable achievement is the DeepMets® Brain Metastasis Image Analysis System, developed in collaboration with Taipei Veterans General Hospital. This system received Taiwan FDA (TFDA) certification as a Software as a Medical Device (SaMD) in 2022, marking it as the first homegrown AI medical device for MRI imaging approved by the TFDA. The company also provides a federated learning platform for medical professionals and AI experts, which ensures data privacy and accelerates the global adoption of AI in healthcare by enabling multi-site, multi-specialty model integration without centralizing sensitive patient data.

Their comprehensive suite of AI tools includes generative AI (Fed-GPT) for drafting clinical reports and administrative documents, AI models for aiding lesion identification during medical procedures, and automated health condition tracking for clinical trial prognosis evaluations. TAIMedimg’s focus extends to various medical imaging applications, including pulmonary hypertension detection (TAIMedImg PHDS) and osteoporosis and sarcopenia diagnostics (VeriOsteo OP), demonstrating a commitment to improving diagnostic accuracy and efficiency across multiple medical specialties.

Focus Areas

AI medical imaging federated learning brain metastasis detection pulmonary hypertension prediction bone mineral density assessment generative AI for medical writing progression tracking smart labeling COVID-19 pneumonia screening

Business Intelligence

Partnerships	GE Healthcare, Taipei Veterans General Hospital, National Taiwan University Hospital, University of the Philippines Manila, U.S. Centers for Disease Control and Prevention (CDC), Samsung Medical Center (South Korea), COMSATS University Islamabad (Pakistan), Kaohsiung's four major medical centers, Taichung Veterans General Hospital
Technology	Federated learning platform (FedMed.tw, TAIFA), AI inference module, DICOM Radiotherapy Structure Sets (RTSS) converter module, generative AI (Fed-GPT)
FDA Clearances	1 cleared products (estimated)

What Physicians Need to Know

Core AI Medical Imaging Platform

Taiwan Medical Imaging leverages advanced AI for comprehensive medical image analysis. Their core platform is built on deep learning models, enabling precise detection, segmentation, and quantification across various imaging modalities. A key differentiator is their adoption of **federated learning**, allowing for collaborative model training across multiple institutions without compromising patient data privacy or requiring data transfer. This ensures robust, generalizable AI models while adhering to strict data governance. They likely utilize cloud-agnostic architectures for scalability and integrate with existing PACS/RIS systems via standard protocols like DICOM.

Disease-Specific AI Diagnostics & Prediction

The company offers specialized AI solutions for critical medical conditions. This includes highly accurate **brain metastasis detection**, aiding oncologists in early diagnosis and treatment planning. Their **pulmonary hypertension prediction** capabilities can identify at-risk patients earlier, potentially improving outcomes. For musculoskeletal health, they provide **bone mineral density assessment**, assisting in osteoporosis screening and management. Furthermore, their rapid **COVID-19 pneumonia screening** tool demonstrates their agility in addressing urgent public health needs, providing quick and reliable diagnostic support during outbreaks.

AI-Powered Workflow & Productivity Tools

Beyond diagnostics, Taiwan Medical Imaging develops AI tools designed to enhance physician workflow and efficiency. Their **generative AI for medical writing** can automate the creation of reports, summaries, and documentation, significantly reducing administrative burden and freeing up physician time for patient care. **Progression tracking** tools provide longitudinal analysis of patient conditions, enabling more informed treatment adjustments and monitoring disease evolution. Additionally, **smart labeling** capabilities streamline the annotation process for medical images, accelerating AI model development and customization.

Physician Tip

For physicians, Taiwan Medical Imaging's solutions offer several key advantages: **enhanced diagnostic accuracy and speed** for critical conditions like brain metastasis and pulmonary hypertension, leading to earlier interventions. The use of **federated learning ensures data privacy and security**, a paramount concern in healthcare. Their **generative AI for medical writing drastically reduces documentation time**, allowing more focus on patient interaction. **Progression tracking** provides valuable insights for long-term patient management, while **COVID-19 screening** offers rapid support during emergencies. These tools are designed to integrate seamlessly into existing workflows, augmenting clinical decision-making and improving overall efficiency.

Taiwan Medical Imaging's solutions are designed for seamless integration with existing hospital information systems (HIS), Picture Archiving and Communication Systems (PACS), and Radiology Information Systems (RIS) through standard protocols like DICOM and HL7. They likely offer API access for custom integrations and cloud-based deployment options for scalability and accessibility.

At a glance

Founded 2019

HQ Kaohsiung, Taiwan (Taiwan AI Labs has an office in Kaohsiung and collaborates with local medical centers there). · Taiwan

CEO Ethan Tu (Founder of Taiwan AI Labs, parent organization of TAIMedimg)

Funding Unfunded

FDA clearances 1 (estimated)

Products 1

Products by Taiwan Medical Imaging

1 product in the directory

TAIMedImg DeepMets

Taiwan Medical Imaging Co.

Oncology AI

TAIMedImg DeepMets is an AI-powered software for automated brain metastasis contouring on MRI, accelerating radiation therapy planning and enhancing diagnostic accuracy and workflow efficiency.

Contact for pricing.

What the Web Says

Taiwan Medical Imaging (TMI) appears to be a company with a strong focus on medical imaging technology, particularly in areas like PACS and radiology solutions. While specific product reviews are less prevalent on major review sites, the company's employer reviews suggest a generally positive work environment, though some areas for improvement exist.

Overall: Mixed

Strengths

Positive work environment and company culture (Glassdoor)
Good opportunities for learning and development (Glassdoor)
Competitive salary and benefits (Glassdoor)
Focus on advanced medical imaging technology (general industry perception)
Stable company with long-term prospects (Glassdoor)
Supportive colleagues and management (Glassdoor)

Limitations

Limited public product reviews on major platforms like G2, Capterra, or Reddit
Specific details on product features and user experience are scarce in public reviews
Potential for long working hours in some departments (Glassdoor)
Communication could be improved in some areas (Glassdoor)
Specific criticisms of product functionality are not readily available
Lack of readily available independent healthcare IT reviewer opinions

Based on reviews from: Glassdoor, G2 (searched, limited results), Capterra (searched, limited results), Reddit (searched, limited results), Healthcare IT Reviewers (searched, limited results)

Last updated: 2026-07-19

Videos

News, demos, and interviews about Taiwan Medical Imaging.

Loading videos...

Videos load interactively. If none appear, search YouTube for Taiwan Medical Imaging →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

What specific AI medical imaging products does Taiwan Medical Imaging offer for conditions like brain metastasis, pulmonary hypertension, or bone mineral density assessment?

Taiwan Medical Imaging, through its associated efforts like Taiwan AI Labs, offers the DeepMetsu00ae Brain Metastasis Image Analysis System, which is TFDA-certified for detecting brain metastases on MRI scans. While specific products for pulmonary hypertension prediction and bone mineral density assessment by 'Taiwan Medical Imaging' are not explicitly detailed, the company's focus on AI-assisted diagnostics suggests capabilities in leveraging AI to analyze medical images for various conditions.

How does Taiwan Medical Imaging utilize federated learning to ensure data privacy and enhance its AI models?

Taiwan Medical Imaging emphasizes federated learning, allowing AI models to be trained and improved using decentralized datasets from multiple institutions without directly sharing sensitive patient data. This approach ensures patient privacy and compliance with regulations like GDPR, while enabling collaborative model development and continuous enhancement of diagnostic accuracy.

What regulatory clearances and compliance standards does Taiwan Medical Imaging adhere to for its AI medical imaging solutions?

Taiwan Medical Imaging's products, such as the DeepMetsu00ae Brain Metastasis Image Analysis System, have received certification from Taiwan's Food and Drug Administration (TFDA) as Software as a Medical Device (SaMD). The company aligns with international standards for trustworthy and responsible AI, and medical devices in Taiwan generally require pre-market approval from the TFDA, adhering to classifications similar to the US FDA.

How can Taiwan Medical Imaging's generative AI tools assist physicians and healthcare administrators with medical writing and documentation?

Taiwan Medical Imaging provides generative AI tools, such as Fed-GPT, that can significantly streamline medical writing by automating the drafting of preliminary reports, summarizing key findings from imaging studies, and assisting with clinical documentation. These tools aim to reduce administrative burden and improve efficiency for healthcare professionals in tasks like routine report transcription and drafting research papers.

What features does Taiwan Medical Imaging offer for progression tracking and smart labeling to improve diagnostic workflow and patient management?

Taiwan Medical Imaging's AI solutions include features for progression tracking, enabling longitudinal assessment of prognostic understanding for treatment follow-up. They also incorporate smart labeling tools that automatically annotate relevant findings, which can enhance diagnostic accuracy, facilitate differential diagnosis, and improve workflow efficiency for clinicians.

What was Taiwan Medical Imaging's involvement in COVID-19 pneumonia screening, and what are their future plans for new AI applications?

Taiwan Medical Imaging Co. jointly developed an AI system approved by the TFDA for rapid COVID-19 pneumonia screening on chest X-rays, aiding in early detection and triage. Looking ahead, the company, through efforts like Taiwan AI Labs, is continuously researching new AI applications, including predictive analytics for various diseases, and actively seeking strategic partnerships to expand its impact in smart healthcare.

Can you describe Taiwan Medical Imaging's pricing model and the level of support and training provided for their AI solutions?

While specific pricing details are not publicly available, medical imaging services in Taiwan are generally more affordable than in some Western countries. Companies in this sector typically offer subscription-based models tailored to institutional needs, alongside comprehensive onboarding, ongoing technical support, and user training to ensure successful implementation and adoption of their AI solutions.

What is the company stability of Taiwan Medical Imaging, and what types of partnerships do they engage in to advance their technology?

Taiwan Medical Imaging, particularly through its association with Taiwan AI Labs, appears to be a stable and growing entity, backed by collaborations with major medical centers like National Taiwan University Hospital and involvement in national alliances. They actively engage in partnerships with academic institutions, healthcare providers, and technology partners to innovate, expand market reach, and align with international standards for trustworthy AI.

Related Companies

Suggest an Edit →